Phagocytic efficacy of macrophage-like cells as a function of cell cycle and Fcγ receptors (FcγR) and complement receptor (CR)3 expression

Clinical and Experimental Immunology

Volumn 145, Issue 2, 2006, Pages 380-387

  Luo, Y ^a   Cook, E ^a   Fries, B C ^a   Casadevall, A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Cell cycle; CR3; Fc R; Macrophage; Phagocytosis

Indexed keywords

COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 3; FC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYPTOCOCCUS NEOFORMANS; FLUORESCENCE ACTIVATED CELL SORTING; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAINING;

ANIMALS; CELL CYCLE; CELL LINE; CELL SIZE; COMPLEMENT C3; CRYPTOCOCCUS NEOFORMANS; FLOW CYTOMETRY; MACROPHAGE-1 ANTIGEN; MACROPHAGES, PERITONEAL; MICE; PHAGOCYTOSIS; RECEPTORS, FC;

EID: 33745933081     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03132.x     Document Type: Article

References (26)

1. Kaczmarek L. Protooncogene expression during the cell cycle. Lab Invest 1986; 54:365-76.
2. Hsu SC, Qi M, DeFranco DB. Cell cycle regulation of glucocorticoid receptor function. EMBO J 1992; 11:3457-68.
3. Hsu S-C, DeFranco DB. Selectivity of cell cycle regulation of glucocorticoid receptor function. J Biol Chem 1995; 270:3359-64.
4. Xaus J, Comalada M, Barrachina M et al. The expression of MHC class II genes in macrophages is cell cycle dependent. J Immunol 2000; 165:6364-71.
5. Gandour D, Walker W. Macrophage cell cycling: influence on Fc receptors and antibody-dependent phagocytosis. J Immunol 1983; 130:1108-12.
6. Walker WS, Beelen RH. Macrophage cell cycling: influence of proliferative state on the antibody-mediated activities of rat resident peritoneal macrophages. Cell Immunol 1988; 111:492-500.
7. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999; 17:593-623.
8. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol 2002; 20:825-52.
9. van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med 1968; 128:415-35.
10. Westermann J, Ronneberg S, Fritz FJ, Pabst R. Proliferation of macrophage subpopulations in the adult rat: comparison of various lymphoid organs. J Leukoc Biol 1989; 46:263-9.
11. De Bakker JM, De Wit AW, Onderwater JJ, Ginsel LA, Daems WT. On the origin of peritoneal resident macrophages. I. DNA synthesis in mouse peritoneal resident macrophages. J Submicrosc Cytol 1985; 17:133-9.
12. Cinatl J, Paluska E, Chudomel V, Malaskova V, Elleder M. Culture of macrophage cell lines from normal mouse bone marrow. Nature 1982; 298:388-9.
13. Stewart C, Lin H, Adles C. Proliferation and colony-forming ability of peritoneal exudate cells in liquid culture. J Exp Med 1975; 141:1114-32.
14. Stewart CC. Formation of colonies by mononuclear phagocytes outside the bone marrow. In: von Furth R, ed. Mononuclear phagocytes: functional aspects. Part I. Dordrecht, the Netherlands: Martinus-Nijhoff, 1980:377.
15. Stewart CC. Murine mononuclear phagocytes from bone marrow. In: Adams D, Edelson PJ, Koren HS, eds. Methods for studying mononuclear phagocytes. New York: Academic Press, 1981:5-20.
16. Forbes IJ. Mitosis in mouse peritoneal macrophages. J Immunol 1966; 96:734-43.
17. Ralph P, Prichard J, Cohn M. Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity. J Immunol 1975; 114:898-905.
18. Luo Y, Tucker SC, Casadevall A. Fc- and complement-receptor activation stimulates cell cycle progression of macrophage cells from G1 to S. J Immunol 2005; 174:7226-33.
19. Franzot SP, Mukherjee J, Cherniak R, Chen L-C, Hamdan JS, Casadevall A. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 1998; 66:89-97.
20. Fries BC, Taborda CP, Serfass E, Casadevall A. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 2001; 108:1639-48.
21. Watarai M, Kim S, Erdenebaatar J et al. Cellular prion protein promotes brucella infection into macrophages. J Exp Med 2003; 198:5-17.
22. Unkeless J. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 1979; 150:580-96.
23. Zhong Z, Pirofski L-A. Antifungal activity of a human antiglucuronoxylomannan antibody. Clin Diagn Lab Immunol 1998; 5:58-64.
24. Taborda CP, Casadevall A. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 2002; 16:791-802.
25. Kozel TR, Mastroianni RP. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis. Infect Immun 1976; 14:62-7.
26. Luberto C, Martinez-Marino B, Taraskiewicz D et al. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans. J Clin Invest 2003; 112:1080-94.